Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
1d
News Medical on MSNSGLT2 inhibitors tied to lower risk of dementia, Parkinson’s disease, suggests studyA class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study ...
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...
1d
HealthDay on MSNSome Diabetes Meds Could Lower Odds for Dementia, Parkinson'sA specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...
New data suggest that current recommendations overstate the proportion of patients who would receive significant kidney ...
A recent study suggests that a class of diabetes medications could be linked to a reduced risk of developing dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results